Oura has agreed to acquire Counsel Health, an AI-native primary care startup, for $625 million. The deal marks a significant expansion for the ring maker as it moves further into health services beyond wearable hardware.
The acquisition comes just weeks after Oura indefinitely postponed its own initial public offering, which had been expected to raise up to $2.2 billion. The company cited uncertainty in the IPO market as the reason for the delay, and the Counsel Health deal suggests Oura is continuing to deploy capital and build out its business while the public markets remain unsettled.
Counsel Health brings an AI-driven approach to primary care, an area where technology companies have been increasingly active. For Oura, whose rings track sleep and other health metrics, adding a care provider could create a more complete health offering that connects data with actual clinical services. The combination would position Oura not merely as a device company that sells hardware and software subscriptions, but as a participant in the delivery of care itself, a far more ambitious role than the one it has occupied to date.
The $625 million price tag makes this a substantial bet for Oura. It is a sum large enough to invite scrutiny from any future public investors, who will want to see evidence that the acquisition generates real revenue and clinical traction rather than serving as a costly detour. How the company integrates Counsel Health's care model with its existing products will be a key question as it prepares for an eventual return to the public markets. Oura has not disclosed a timetable for that return, and the decision to press ahead with a major acquisition while its offering remains on hold signals that management intends to keep building the business rather than waiting for market conditions to improve.